Atlas Trials

B-cell Childhood Acute Lymphoblastic Leukemia

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch B-cell Childhood Acute Lymphoblastic Leukemia

RecordFirmDate
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT (NCT04746209)Medical College of Wisconsin2021-02-01
Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia (NCT01990807)Chinese Academy of Medical Sciences2012-10-01
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia (NCT01625143)Children's Oncology Group2012-06-01
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia (NCT01540578)Children's Oncology Group2012-02-01
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT00873093)National Cancer Institute (NCI)2009-03-01
Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma (NCT00867529)Fred Hutchinson Cancer Center2009-02-01
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT01093586)Case Comprehensive Cancer Center2007-09-01
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission (NCT00382109)Children's Oncology Group2007-03-01
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (NCT00381680)Children's Oncology Group2007-03-01
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT00101205)National Cancer Institute (NCI)2004-11-01
Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia (NCT00058461)National Cancer Institute (NCI)2003-11-01
Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate (NCT00898404)Children's Oncology Group2003-11-01
Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00061945)National Cancer Institute (NCI)2003-06-01
Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation (NCT00052520)Fred Hutchinson Cancer Center2002-09-01

Track B-cell Childhood Acute Lymphoblastic Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.